Intrexon | 営業経費





営業経費 変化する 日付
Agenus USD -274.14M 80.46M 2025-09
Alaunos Therapeutics USD 1.19M 428K 2025-09
Amgen USD 5.9B 773M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Heron Therapeutics USD 38.47M 4M 2024-09
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 67M 8M 2025-09
MannKind USD 63.35M 2.51M 2025-09
Merck USD 10.16B 558M 2025-12
Novartis USD 9.86B 115M 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Veracyte USD 108.76M 7.09M 2025-09
Xencor USD 68.52M 8.26M 2025-09


Intrexon 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.